Suspected de novo Hepatitis B in a Patient Receiving Anti-Tumor Necrosis Factor Alpha Therapy for the Treatment of Crohn's Disease

Publisher： Karger

E-ISSN： 1662-0631|8|1|44-50

ISSN： 1662-0631

Source： Case Reports in Gastroenterology, Vol.8, Iss.1, 2014-01, pp. : 44-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-α Monoclonal Antibody Treatment for Crohn's Disease

By  

Digestion, Vol. 88, Iss. 1, 2013-06 ,pp. : 17-19

Karger

Access to resources Recommend Favorite

Anti-Tumor Necrosis Factor Nonresponders in Crohn’s Disease: Therapeutic Strategies

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 351-357

Karger

Access to resources Recommend Favorite

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease

By  

Digestion, Vol. 78, Iss. 4, 2008-12 ,pp. : 195-200

Karger

Access to resources Recommend Favorite

Patient’s Perspectives Important for Early Anti-Tumor Necrosis Factor Treatment in Inflammatory Bowel Disease

By  

Digestion, Vol. 79, Iss. 1, 2009-02 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

Suboptimal Clinical Response to Anti-tumor Necrosis Factor alpha (TNFα) Antibody Therapy in a Patient with Severe Rheumatoid Arthritis and Lymphadenopathy: CASE REPORT

By Saeki Yukihiko   Ohshima Shiro   Mima Toru   Sasai Mitsuko   Nishioka Katsuhiro   Shimizu Masatoshi   Suemura Masaki   McCloskey Richard   Kishimoto Tadamitsu  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 303-305

Informa Healthcare

Access to resources Recommend Favorite